News • Noninvasive stratification
Multiplex PET helps doctors 'see' bowel cancer
Multiplex PET imaging technology could provide a ground-breaking new approach for diagnosing and treating bowel cancer patients, according to scientists in Glasgow.
Oncology
News • Chemotherapy and novel surgery technique
Study explores new approach to 'inoperable' pancreatic cancer
US oncologists are exploring a new combined chemotherapy and surgical approach to safely remove advanced pancreatic tumors that were previously considered inoperable.
News • Voxel-wise classification
Deep learning tool uses MRI to enhance brain tumor diagnosis
A novel AI-based, non-invasive diagnostic tool enables accurate brain tumor diagnosis, outperforming current classification methods. The tool leverages MRI information to aid clinical decision making.
News • Personalised oncology
New platform to significantly reduce cancer drug testing and screening time
In a breakthrough for personalised oncology, scientists have developed and demonstrated a novel platform that can significantly reduce the time needed to determine the efficacy of anti-cancer drugs.
Article • Proof-of-concept study
First test for the early detection of head and neck cancer being developed
Most head and neck tumours are discovered in late due in part to the fact that there is no established method for early detection. To close this gap, a team at oncgnostics, a biotechnology company based in Jena, Germany, is participating in a study which aims to develop an early detection test.
News • Appeal for better approval conditions
AI in personalised cancer medicine: “A fundamental change is needed”
AI technology holds promise for personalised cancer therapies. However, rigid and slow approval requirements impede its introduction, say experts – and point out how this might be changed.
News • CTC, ctDNA and exosomes in PCa management
Prostate cancer: Blood-based liquid biopsies yield valuable information
US researchers discuss three blood-based liquid biopsies, namely circulating tumor cells, circulating tumor DNA and tumor-derived exosomes, as they relate to prostate cancer management.
News • Friend and foe in one
Breast cancer: The paradoxical role of white blood cells
White blood cells found in breast tumors can both help and hinder the spread of cancer cells to other organs, a new study from Karolinska Institutet shows.
News • Encouraging results of DARS trial
A ‘new gold standard’ for head and neck cancer radiotherapy
New research suggests a new approach to precision radiotherapy can reduce the risk of swallowing problems for patients, without impacting the success of treatment.
News • Interaction with cancer patients
Experts raise ethics concerns posed by patient-facing AI in oncology
Bioethics researchers call on medical societies, government leaders, clinicians, and researchers to work together to ensure AI-driven healthcare preserves patient autonomy and respects human dignity.
News • IC before CRT
Cervical cancer: Improved treatment course increases survival, reduces recurrence
New trial results suggest that a short course of induction chemotherapy prior to chemoradiation could reduce the rate of relapse and death among patients with locally advanced cervical cancer.
News • Supportive communication reduces uncertainty
One of clinicians' mightiest weapons against breast cancer? Empathy
Clinicians who show more empathy promote better psychological health among breast cancer patients, according to a new US study examining how oncology doctors facilitate psychological well-being.
News • Radiation and immunotherapy
Promising combination therapy against "cold" breast cancer tumors
US researchers have discovered that radiation therapy combined with two types of immunotherapy can control tumors in preclinical models of triple negative breast cancer.
News • Biomarker-based predictions
AI drives precision oncology for colorectal cancer
For the first time, researchers show that AI-based predictions can deliver comparable results to clinical tests on biopsies of patients with colorectal cancer (CRC).
News • Patchy recommendations
Errors and half-truths plague cancer treatment plans generated by ChatGPT
Experts from Brigham and Women’s Hospital have tasked ChatGPT to generate recommendations for cancer treatment – with some promise, but ultimately inadequate results.
News • Biopharmaceutical business
Precision approach to significantly reduce R&D costs for cancer drugs
A new analysis exploring the finances of bringing new cancer drugs to market has found that precision oncology drugs could be $1 billion cheaper to develop than non-precision drugs.
Article • RFA, MWA, CRYO and IRE under scrutiny
Thoracic interventions: new tools in the arsenal
Experts presented state-of-the-art and emerging techniques to treat chest tumours and discussed common issues in the management of pneumothorax at RSNA 2022. Current ablation methods in the thorax include radiofrequency ablation (RFA), microwave ablation (MWA), cryoablation (CRYO), irreversible electroporation (IRE) and pulsed electric field.
Article • Oncology imaging
The expanding role of CT in lung cancer management
While screening programs for several of the commonest cancers are now well established, lung cancer screening has yet to reach anywhere near the same proportion of at-risk patients.
News • Precision oncology
Genomic sequencing benefits only 5% of cancer patients
Genomic sequencing panels as part of personalised cancer treatment have been found to only benefit one in 20 patients they are currently used for, according to a study by CNIO.
Article • Cancer patients at risk
Blood test detects risk of neurotoxicity from CAR T-cell therapy
Chimeric antigen receptor (CAR) T-cell therapy is an immunotherapy treatment that re-engineers a patient’s own T-cells to help them attack malignant tumour cells. It has been very effective in the treatment of blood cancers, including certain types of leukaemia and lymphoma. However, two serious side effects are common as a result of the treatment: cytokine release syndrome (CRS) and immune…
Article • Progress, limitations, and opportunities
Precision oncology: incredible potential, but not a miracle cure
Unanswered questions are hampering clinicians in their efforts to get the best out of a precision medicine approach for their patients. Speaking at the Genomics and Precision Medicine Expo in London at the end of May, cancer educator Dr Elaine Vickers said the benefits of being matched to an investigational drug remain questionable for most people with advanced cancer.
News • Targeted therapy
Biliary duct cancer: the future of precision oncology
Gene alterations in biliary tract cancer offer potential targets for current or future precision therapies. This is demonstrated by a new study from Vienna.
News • Potential for new treatments
Researchers find new subtypes for ovarian cancer
New research from the University of Helsinki increases the understanding of ovarian cancer: the identification of new subtypes could help discover new treatments.
Article • 21-day radiotherapy
A safe and effective “shortcut” for early breast cancer treatment
Patients with early-stage breast cancer who have an elevated risk of having tumour recurrence now have the option to take a course of radiotherapy following breast conservation surgery that is only three weeks long, half the time of conventional radiotherapy treatment.
News • Imaging equipment
Dunlee unveils oncology bundles at ECR 2023
Dunlee unveiled its new oncology bundles onsite at ECR. The bundles combine components that have been tested and verified to work together so clinicians can offer state-of-the-art onboard Cone Beam CT (CBCT) in facilities.
